Serial #79419571
DEAD

Serial Number

79419571

Owner

TAIHO PHARMACEUTICAL CO., LTD.

Filing Date

Jan 23, 2025

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79419571 Trademark

Serial Number: 79419571

Serial #79419571 is a trademark filed by TAIHO PHARMACEUTICAL CO., LTD. on January 23, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

TAIHO PHARMACEUTICAL CO., LTD. (107 trademarks)

CHIYODA-KU, TOKYO , JP

Entity Type: 03

Trademark Details

Filing Date

January 23, 2025

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for the treatment of tumor; pharmaceutical preparations for the treatment of cancer; anti-cancer preparations; tumor suppressing agents; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders; pharmaceutical preparations for the treatment of muscular diseases and disorders; pharmaceutical preparations for the treatment of urological diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders; pharmaceutical preparations for the treatment of gastroesophageal reflux diseases and disorders; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of immune diseases and disorders; pharmaceutical preparations for the treatment of diseases of the central and peripheral nervous system; pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of diseases of the blood; pharmaceutical preparations for treating hematological disorders; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for use in chemotherapy; anti-emetic medicines; pharmaceutical preparations for the treatment of pain; analgesic preparations; antiphlogistic preparations; chemical reagents for medical purposes in the field of oncology..

Filing History

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
May 20, 2026 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
May 20, 2026 ABN2
ASSIGNED TO EXAMINER
May 19, 2026 DOCK
REFUSAL PROCESSED BY IB
Nov 22, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 30, 2025 RFCS
REFUSAL PROCESSED BY MPU
Oct 30, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 15, 2025 RFCR
NON-FINAL ACTION WRITTEN
Oct 14, 2025 CNRT
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Oct 4, 2025 CORN
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Sep 22, 2025 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 16, 2025 RFCR
NON-FINAL ACTION WRITTEN
Aug 15, 2025 CNRT
ASSIGNED TO EXAMINER
Jul 2, 2025 DOCK
CORRECTION TRANSACTION RECEIVED FROM IB
Apr 12, 2025 CRCV
APPLICATION FILING RECEIPT MAILED
Mar 28, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 28, 2025 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Mar 26, 2025 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 20, 2025 REPR